Mink Therapeutics Stock Target Price and Analyst Consensus
| INKT Stock | USD 6.60 1.09 19.78% |
The current analyst and expert consensus on Mink Therapeutics is Strong Buy, with 2 strong buy opinions. The current projected Mink Therapeutics target price consensus is 6.50 with 3 analyst opinions. Check out Macroaxis Advice on Mink Therapeutics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For more information on how to buy Mink Stock please use our How to Invest in Mink Therapeutics guide.The most common way Mink Therapeutics analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Mink Therapeutics executives and customers to further validate their buy or sell advice. Please note, the number of analysts providing the opinion is not sufficient to provide adequate consensus on Mink Therapeutics. We encourage you to use your own analysis of Mink Therapeutics to validate this buy or sell advice. Mink Therapeutics buy-or-sell recommendation module provides average expert sentiment on the projected Mink Therapeutics target price to derive its highest and lowest estimates based on projected price volatility of 9.7875.
Lowest Forecast 5.92 | Highest Forecast 7.22 | Target Price 6.5 |
Mink |
It's important to approach Mink Therapeutics' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Mink Therapeutics Target Price Consensus
Mink target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Mink Therapeutics' target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 3 | Strong Buy |
Most Mink analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Mink stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Mink Therapeutics, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationMink Therapeutics Target Price Projection
Mink Therapeutics' current and average target prices are 6.60 and 6.50, respectively. The current price of Mink Therapeutics is the price at which Mink Therapeutics is currently trading. On the other hand, Mink Therapeutics' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Mink Therapeutics Market Quote on 31st of January 2025
Target Price
Analyst Consensus On Mink Therapeutics Target Price
Mink Therapeutics Analyst Ratings
Mink Therapeutics' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Mink Therapeutics stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Mink Therapeutics' financials, market performance, and future outlook by experienced professionals. Mink Therapeutics' historical ratings below, therefore, can serve as a valuable tool for investors.Analyst Consensus Breakdown
Average Consensus Estimates
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Mink Therapeutics price targets
Mink Therapeutics' stock target price is an estimate of its future price, usually made by analysts. Using Mink Therapeutics' target price to determine if it is a suitable investment can be done through the following steps:- Look at Mink Therapeutics' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Mink Therapeutics' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Mink Therapeutics Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Mink Therapeutics is a key component of Mink Therapeutics valuation and have some predictive power on the future returns of a Mink Therapeutics.Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Driverless Cars Invested over 300 shares | |
 | Hedge Favorites Invested over 50 shares | |
 | Impulse Invested over 100 shares | |
 | Blockchain Invested few shares | |
 | Banking Invested over 30 shares | |
 | Macroaxis Index Invested few shares | |
 | Power Assets Invested over 300 shares | |
 | Warren Buffett Holdings Invested over 60 shares | |
 | Manufacturing Invested over 30 shares | |
 | ESG Investing Invested few shares |
Additional Tools for Mink Stock Analysis
When running Mink Therapeutics' price analysis, check to measure Mink Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mink Therapeutics is operating at the current time. Most of Mink Therapeutics' value examination focuses on studying past and present price action to predict the probability of Mink Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mink Therapeutics' price. Additionally, you may evaluate how the addition of Mink Therapeutics to your portfolios can decrease your overall portfolio volatility.